Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesbrough,England

Abstract

Herpes simplex virus (HSV) infection occurs worldwide but its epidemiology varies between different countries and between groups of individuals. Seroprevalence of HSV-1 and HSV-2 antibodies is a more accurate method of determining epidemiology of this infection.

In this cross-sectional study, 467 blood samples were obtained from women attending the genitourinary medicine clinic (GUM) and antenatal clinic (ANC) in Middlesbrough, England. Analysis of their blood samples showed that 69.5% GUM patients had HSV-1 antibodies and the figure was 54.5% in the ANC patients, p<0.0001, with odds ratio 1.9 (95% CI 1.30 to 2.78) for higher prevalence in the GUM group. Also, for HSV-2 antibodies, the seroprevalence was 21.6% for GUM and 8.1% for ANC patients, p<0.0001, with an odds ratio of 3.13 (95% CI 1.70 to 6.02) for higher prevalence in the GUM group. The overall prevalence for HSV-1 is 63.2% and for HSV-2 is 15.8%. Many of these patients were asymptomatic and constitute a potential source for spreading the virus.

Knowledge of HSV seroprevalence can help in planning sexual health promotion strategies.

Keywords

Antenatal care antibodies female populations health promotion herpes simplex virus

Get full access to this article

View all access options for this article.

References

Simms I , Hughes G , Swan AV , Rogers PA , Catchpole M. New cases seen at GUM clinics: England 1996 . Commun Dis Rep CDR Supplement 1998;8: 1-11

Hook EW , Cannon RO , Nahmias AJ , Lee FF , Campbell CH , Glasser D , et al . Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals . J Infect Dis 1992;165(2): 251-255

Woolley PD , Kudesia G. Incidence of herpes simplex virus type-1 and type-2 from patients with primary (first-attack) genital herpes in Sheffield . Int J STD AIDS 1990;1(3): 184-186

Tayal SC , Pattman RS. High prevalence of herpes simplex virus type I in female anogenital herpes simplex in Newcastle-upon-Tyne 1983-92 . Int J STD AIDS 1994;5(5): 359-361

Cunningham AL , Lee FK , Ho DW , Field PR , Law CL , Packham DR , et al . Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics . Med J Aust 1993;158(8): 525-528

Perkins NL , Coughlan EP , Franklin RA , Reid MR , Taylor J. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients . NZ Med J 1996;109(1032): 402-405

Oliver L , Wald A , Kim M , Zeh J , Selke S , Ashley R , et al . Seroprevalence of herpes simplex virus infections in a family medicine clinic . Arch Fam Med 1995;4(3): 228-232

Breinig MK , Kingsley LA , Armstrong JA , Freeman DJ , Ho M. Epidemiology of genital herpes in Pittsburgh: Serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections . J Infect Dis 1990;162(2): 299-305

Rosenthal SL , Stanberry LR , Biro FM , Slaoui M , Francotte M , Koutsoukos M , et al . Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents . Clin Infect Dis 1997;24(2): 135-139

10.

Cowan FM , Johnson AM , Ashley R , Corey L , Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations . BMJ 1994;309(6965): 1325-1329

11.

Sherman KJ , Daling JR , Chu J , Weiss NS , Ashley RL , Corey L. Genital warts, other sexually transmitted diseases, and vulvar cancer . Epidemiology 1991;2(4): 257-262

12.

Brown ZA , Benedetti J , Selke S , Ashley R , Watts DH , Corey L. Asymptomatic maternal shedding of herpes simplex virus at the onset of labour: relationship to preterm labour . Obstet Gynaecol 1996;87: 483-487

13.

Ashley RL , Dalessio J , Burchett S , Brown Z , Berry S , Mohan K , et al . Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth . J Clin Invest 1992;90(2): 511-514

14.

Cone RW , Hobson AC , Brown Z , Ashley RL , Berry S , Winter C , et al . Frequent detection of genital HSV DNA by PCR among pregnant women . JAMA 1994;272: 792

15.

Koutsky LA , Stevens CE , Holmes KK , Ashley RL , Kiviat NB , Critchlow CW , et al . Underdiagnosis of genital herpes by current clinical and viral-isolation procedures . N Engl J Med 1992;326(23): 1533-1539

16.

Watson PG , Pattman RS , Sankar KN , Wardropper AG. The value of an additional diagnostic test for first attacks of genital herpes . Int J STD AIDS 1995;6: 453

17.

Ashley RL , Militoni J , Lee F , Nahmias A , Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera . J Clin Microbiol 1988;26(4): 662-667

18.

Slomka MJ , Ashley RL , Cowan FM , Cross A , Brown DW. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2 specific humoral responses: Comparison with western blot assay . J Virological Methods 1995;55(1): 27-35

19.

Field PR , Ho DW , Irving WL , Isaacs D , Cunningham AL. The reliability of serological tests for the diagnosis of genital herpes: a critique . Pathol 1993; 25(2): 175-179

20.

Munday PE , Vuddamalay J , Slomka MJ , Brown DWG. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes . Sex Transm Infect 1998;74: 175-178